Drug Shipment and Study Conducted at Address: University of Alabama at Birmingham — Birmingham, Alabama

Drug Shipment and Study Conducted at Address: University of Alabama at Birmingham is a clinical research site located in Birmingham, Alabama, United States 35294.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Drug Shipment and Study Conducted at Address: University of Alabama at Birmingham has participated in 1 clinical trials.

Therapeutic areas: Hyperlipidemia.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Drug Shipment and Study Conducted at Address: University of Alabama at Birmingham?

Drug Shipment and Study Conducted at Address: University of Alabama at Birmingham has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Drug Shipment and Study Conducted at Address: University of Alabama at Birmingham conducted?

Drug Shipment and Study Conducted at Address: University of Alabama at Birmingham has 1 clinical trials on record. Their work covers Hyperlipidemia.

Is Drug Shipment and Study Conducted at Address: University of Alabama at Birmingham accredited by Crixeo Health?

Drug Shipment and Study Conducted at Address: University of Alabama at Birmingham has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Drug Shipment and Study Conducted at Address: University of Alabama at Birmingham?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.